We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
183 hedge funds and large institutions have $136M invested in Anavex Life Sciences in 2025 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 54 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
36% more call options, than puts
Call options by funds: $9.68M | Put options by funds: $7.13M
11% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 54
4.01% more ownership
Funds ownership: 38.21% → 42.22% (+4%)
0% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 28
2% less funds holding
Funds holding: 186 → 183 (-3)
55% less capital invested
Capital invested by funds: $300M → $136M (-$165M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
183
Holders Change
-3
Holders Change %
-1.61%
% of All Funds
2.23%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
28
Increased
60
Reduced
54
Closed
28
Calls
$9.68M
Puts
$7.13M
Net Calls
+$2.55M
Net Calls Change
-$1.23M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$6.72M |
| 2 |
Two Sigma Investments
New York
|
+$3.78M |
| 3 |
Goldman Sachs
New York
|
+$3.49M |
| 4 |
Jane Street
New York
|
+$3.37M |
| 5 |
SF
Summit Financial
Parsippany,
New Jersey
|
+$2.81M |
